|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Food and Experimental Nutrition (IAC and PS), Pharmaceutical Science Faculty, and the Statistics Department, Institute of Mathematics and Statistics (LPB), University of São Paulo, São Paulo, Brazil
Background: It has been difficult to identify the appropriate bioactive substance for the development of new functional foods associated with coronary heart disease, because the results of many clinical studies are contradictory.
Objective: The objective of this study was to use the multivariate statistical approach known as principal component analysis (PCA) followed by a mixed model to process data obtained from a meta-analysis aimed at evaluating simultaneously the effect of ingestion of 1 of 3 types of bioactive substances (n3 fatty acids, soluble fibers, and phytosterols) on 1 or more of 4 biomarkers (plasma total cholesterol, triacylglycerol, LDL cholesterol, and HDL cholesterol).
Design: Five independent variables (number of patients per study, dose, age, body mass index, and treatment length) and 4 dependent variables (percentage change in blood total cholesterol, LDL, HDL, and triacylglycerol) from 159 studies and substudies were organized into a matrix. The original values were converted to linear correlation units, which resulted in a new matrix.
Results: Two principal components were enough to explain 63.73% and 84.27% of the variance in the independent and dependent variables, respectively. Phytosterols and soluble fibers had a hypocholesterolemic effect, whereas n3 fatty acids lowered triacylglycerol and increased total, LDL, and HDL cholesterol. The PCA and mixed model showed that this behavior was independent of dose, number of patients per study, age, and body mass index but was associated with treatment length.
Conclusions: PCA is useful for summarizing available scientific information in examinations of health claims for foods and supplements.
Key Words: n3 Fatty acids phytosterols soluble fibers cholesterol multivariate analysis functional foods
This article has been cited by other articles:
![]() |
A. M Zivkovic, J B. German, and A. J Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bonneux Cardiovascular risk models BMJ, July 21, 2007; 335(7611): 107 - 108. [Full Text] [PDF] |
||||
![]() |
E. Theuwissen and R. P. Mensink Simultaneous Intake of {beta}-Glucan and Plant Stanol Esters Affects Lipid Metabolism in Slightly Hypercholesterolemic Subjects J. Nutr., March 1, 2007; 137(3): 583 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hallikainen, L. Toppinen, H. Mykkanen, J. J Agren, D. E Laaksonen, T. A Miettinen, L. Niskanen, K. S Poutanen, and H. Gylling Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Demonty, Y.-M. Chan, D. Pelled, and P. J. Jones Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1534 - 1542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |